文献速递产科母胎医学

引入普遍经阴道宫颈长度筛查项目与早产率降低相关

The introduction of a universal transvaginal cervical length screening program is associated with a reduced preterm birth rate.
PubMed 文献 · Am J Obstet Gynecol · 2022-08-04

本研究包括两部分:法国东南部2012年1月1日至2018年4月30日的多中心前后对照研究,以及2015年5月至2018年7月在17家产科医院开展的前瞻性ECHOCOL队列。引入孕中期普遍宫颈长度筛查后,多因素分析显示早产率显著降低(A期5.8% vs B期5.6%;校正比值比0.92;95%CI 0.89-0.95;P<.0001)。ECHOCOL队列中37周前早产率有降低趋势但未达统计学显著(5.8% vs 5.5%;校正比值比0.72;95%CI 0.51-1.03;P=.068)。

要点

  • 多中心前后对照显示宫颈长度筛查率从A期28.9%升至B期52.9%(OR 2.76;95%CI 2.71-2.80;P<.0001)。
  • 多因素分析显示引入普遍筛查后早产率显著降低(5.8% vs 5.6%;aOR 0.92;95%CI 0.89-0.95;P<.0001)。
  • ECHOCOL队列中37周前早产率降低趋势未达统计学显著(5.8% vs 5.5%;aOR 0.72;95%CI 0.51-1.03;P=.068)。

核心结论

  • 研究显示,在孕中期实施普遍宫颈长度筛查和治疗策略后,早产率显著降低。

研究设计与样本

  • 研究包括两部分:法国东南部2012年1月1日至2018年4月30日所有单胎妊娠24周后分娩妇女的多中心前后对照研究,以及2015年5月至2018年7月在法国东南部17家产科医院前瞻性开展的ECHOCOL队列研究。
  • ECHOCOL队列共纳入3468例患者。
  • 无症状短宫颈(<25 mm)时提供的治疗包括200 mg阴道用黄体酮、宫颈环扎术或子宫托,直至妊娠34周。
  • 临床试验注册号为NCT02598323。

主要发现

  • 多因素分析显示A期与B期之间早产率显著降低(分别为5.8% vs 5.6%;校正比值比0.92;95%CI 0.89-0.95;P<.0001)。
  • 宫颈长度筛查百分比从A期的28.9%显著增加至B期的52.9%(比值比2.76;95%CI 2.71-2.80;P<.0001)。
  • ECHOCOL前瞻性队列3468例患者中,检出38例(1.1%)无症状短宫颈,192例患者早产(其中11例有无症状短宫颈,181例无)。
  • ECHOCOL队列中观察到37周前早产率有降低的明显趋势但未达统计学显著(从5.8%至5.5%;校正比值比0.72;95%CI 0.51-1.03;P=.068)。

关键数值与推荐

  • 无症状短宫颈定义为宫颈长度<25 mm。
  • 短宫颈治疗选项包括200 mg阴道用黄体酮、宫颈环扎术或子宫托,持续至妊娠34周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Midtrimester sonographic short cervix is a good predictor of preterm birth in singleton pregnancies. OBJECTIVE: This study aimed to assess the impact of implementing a universal transvaginal cervical length screening program on preterm birth rate. STUDY DESIGN: This study consisted of 2 parts: a before-and-after multicenter study and a study on the ECHOCOL ("echo"="ultrasound" and "col"="cervix" in French) prospective cohort. We compared the rate of preterm birth before and after the introduction of universal cervical length screening at the time of midtrimester anatomy ultrasound. The multicenter before-and-after regional study included all women with a singleton pregnancy who gave birth after 24 weeks' gestation in the South East of France from January 1, 2012 to April 30, 2018. In parallel, the ECHOCOL cohort study was prospectively conducted from May 2015 to July 2018, including 17 maternity hospitals in the South East region of France. In case of asymptomatic short cervix <25 mm, treatments offered included 200 mg of vaginal progesterone, or cerclage, or a pessary until 34 weeks' gestation. RESULTS: We observed a significant decrease rate of preterm birth between periods A and B after multivariate analysis. (respectively, 5.8% vs 5.6%; adjusted odds ratio, 0.92; 95% confidence interval, 0.89-0.95; P<.0001). In parallel, the percentage of cervical length screening significantly increased from 28.9% in period A to 52.9% in period B (odds ratio, 2.76; 95% confidence interval, 2.71-2.80; P<.0001). Among the 3468 patients of the ECHOCOL prospective cohort, 38 (1.1%) asymptomatic short cervices were detected, and 192 patients gave birth prematurely (11 with an asymptomatic short cervix and 181 without). In the ECHOCOL cohort, a marked but statistically insignificant tendency toward a reduced rate of preterm birth before 37 weeks of gestation was observed (from 5.8% to 5.5%; adjusted odds ratio, 0.72; 95% confidence interval, 0.51-1.03; P=.068). CONCLUSION: This study showed a significantly lower rate of preterm birth after the implementation of a universal cervical length screening and treating policy during the second trimester of pregnancy. The clinical trial was registered under NCT02598323.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Figarella A, Chau C, Loundou A, et al. The introduction of a universal transvaginal cervical length screening program is associated with a reduced preterm birth rate. Am J Obstet Gynecol. 2022. PMID: 35932876. doi:10.1016/j.ajog.2022.07.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。